Getein

D-Dimer

Getein D-Dimer Fast Test Kit (Immunofluorescence Assay) The Getein D-Dimer Fast Test Kit is a rapid and accurate immunofluorescence assay for the quantitative determination of D-Dimer in human plasma or whole blood samples. This test aids in the assessment and evaluation of patients suspected of deep-vein thrombosis (DVT) or pulmonary embolism (PE), providing results within 10 minutes. It is essential for emergency and critical care settings due to its high sensitivity and specificity.

Product description

Getein D-Dimer Fast Test Kit (Immunofluorescence Assay)

The Getein D-Dimer Fast Test Kit is designed for the quantitative determination of D-Dimer in human plasma or whole blood samples. This test aids in the assessment and evaluation of patients suspected of having deep-vein thrombosis (DVT) or pulmonary embolism (PE), providing rapid results within 10 minutes.

Intended Use

The D-Dimer Fast Test Kit (Immunofluorescence Assay) is intended for in vitro quantitative determination of D-Dimer in human plasma or whole blood samples. It is used as an aid in assessing and evaluating patients suspected of deep-vein thrombosis or pulmonary embolism.

About D-Dimer

D-Dimer is a marker of endogenous fibrinolysis and is detectable in patients with deep-vein thrombosis. It has a high negative predictive value and is a sensitive but nonspecific marker of DVT. A negative D-Dimer result can exclude deep-vein thrombosis and pulmonary embolism.

Specifications

Specification Details
Test Item D-Dimer
Sample Type Plasma, Whole Blood
Detection Range 0.1-10.0 mg/L
Storage Condition 4-30℃
Method Immunofluorescence Assay
Test Time 10 Minutes
Cut-off Value 0.5 mg/L
Shelf Life 24 months

Applicable Devices

  • Getein 1100 Immunofluorescence Quantitative Analyzer
  • Getein 1160 Immunofluorescence Quantitative Analyzer
  • Getein 1180 Immunofluorescence Quantitative Analyzer
  • Getein 1200 Immunofluorescence Quantitative Analyzer
  • Getein 1600 Immunofluorescence Quantitative Analyzer
  • Getein 208 Hand-held Integrated System

Clinical Applications

  • Exclusion of venous thromboembolism (VTE)
  • Exclusion of pulmonary embolism (PE)
  • Diagnosis of disseminated intravascular coagulation (DIC)
  • Diagnosis and prognosis of cerebral infarction
  • Evaluation of coagulation status in pregnancy-induced hypertension
  • Diagnosis and prognosis in surgical patients; monitoring thrombolytic therapy